Table of Contents
Montelukast is a leukotriene receptor antagonist widely used in the management of asthma and allergic rhinitis. Understanding its pharmacokinetic profile is essential for pharmacy students to optimize its therapeutic efficacy and safety.
Absorption
Montelukast is rapidly absorbed after oral administration, with peak plasma concentrations typically achieved within 3 to 4 hours. Its absolute bioavailability is approximately 64%, which is unaffected by food intake, allowing flexibility in dosing with or without meals.
Distribution
The drug exhibits high plasma protein binding, approximately 99%, primarily to albumin. This extensive binding limits its distribution to tissues but ensures stable plasma concentrations. Montelukast crosses the blood-brain barrier minimally, reducing central nervous system effects.
Metabolism
Montelukast undergoes minimal hepatic metabolism, primarily through the cytochrome P450 system, especially CYP2C8. Its metabolic pathway results in inactive metabolites, which are excreted mainly via the feces.
Elimination
The elimination half-life of montelukast ranges from 2.7 to 5.5 hours, allowing once-daily dosing in most patients. Approximately 86% of the drug is excreted in feces, and less than 0.2% is recovered in urine, indicating biliary excretion as the primary route.
Pharmacokinetic Considerations
Factors such as age, hepatic impairment, and concomitant medications can influence montelukast’s pharmacokinetics. In pediatric patients, absorption may be slightly reduced, but overall pharmacokinetic parameters remain consistent with adults. Caution is advised when prescribing to patients with hepatic impairment due to decreased metabolism and clearance.
Clinical Implications
Understanding the pharmacokinetic profile of montelukast aids pharmacists in optimizing dosing regimens, managing potential drug interactions, and counseling patients effectively. Its once-daily dosing and favorable safety profile make it a convenient option for long-term management of airway inflammatory conditions.